Medicare CGM Coverage in 2026: Rules, Costs, and What to Do Next

US Diabetes Care · 5 · April 21, 2026

I spoke with three US endocrinology practices and a Medicare benefits advisor to get the 2026 picture straight. The rules have changed more in the past three years than in the prior ten combined, and most patients (and some clinicians) are working from outdated information.

The current rule in one paragraph

As of 2026, Medicare covers a continuous glucose monitor for any diabetic (type 1 or type 2) who meets either of these conditions: uses any insulin, or has a documented history of problematic hypoglycemia. "Any insulin" is the big change — up to 2023 Medicare required intensive insulin therapy (multiple daily injections or a pump). Since the 2023 update a single daily basal insulin also qualifies. The supplies are covered under Medicare Part B durable medical equipment, not Part D prescription drug coverage.

What that looks like in practice

If you qualify, you typically get:

• A Dexcom G7 or FreeStyle Libre 3 Plus system, with sensors shipped every 30 days.
• Coverage at 80% after the annual Part B deductible ($257 in 2026). The remaining 20% is your responsibility unless you have Medigap or Medicare Advantage with lower cost-sharing.
• No out-of-pocket charge if you have full-benefit Medicaid alongside Medicare (dual-eligible).

Typical monthly cost after coverage for a standard-benefit Medicare enrollee: about $20–35 out of pocket for the sensors, $0 for the receiver (one-time), $0 for the transmitter (Dexcom) if covered by the sensor price.

Who does not qualify in 2026

Even in 2026 the following groups still do not automatically qualify:

• Type 2 diabetics on oral medications only, with no insulin.
• Prediabetics.
• People using CGM for weight-loss or wellness reasons.

There are some gestational-diabetes exceptions and some narrow endocrinologist-led research protocols that expand coverage, but as a general rule: no insulin, no Medicare CGM.

The three things Medicare does not pay for

1. Over-the-counter Stelo, Lingo, or Libre Rio. These are not DME-classified — they are consumer wellness products, and Medicare Part B does not cover them. If you want one, you pay retail.
2. Fingerstick supplies once you're on CGM. Once Medicare approves CGM, it stops paying for most test strips. You can still buy them retail — budget around $20/month.
3. Apps or premium app tiers. The free tier of the Dexcom or Libre app is covered via the device. Premium analytics subscriptions are on you.

Most common denials and how to fix them

Three denial patterns I heard repeatedly:

1. "Documentation of insulin use is missing." The easy fix is a fresh clinical note from your prescribing physician stating your current insulin regimen explicitly. Endos usually turn this around in a week.
2. "Face-to-face visit requirement not met." Medicare requires an in-person or telehealth visit documenting diabetes status in the last 6 months. If your last visit was longer, you need a new one before the DME claim will go through.
3. "Supplier out of network." Only certain DME suppliers have Medicare approval for CGM. If your pharmacy is denied, switch to one of the Medicare-contracted suppliers — usually Byram, CCS Medical, or Edgepark, who handle this volume. Your endo's office can advise.

Medicare Advantage (Part C) — check your plan

Medicare Advantage plans are required to cover what Original Medicare covers, but they can add restrictions: prior authorization, in-network suppliers, step therapy rules. If you are on Medicare Advantage and your CGM claim is denied, the rules above still apply — but the procedure for appeal runs through the plan's member services, not directly through CMS. The outcome is usually the same; the paperwork path is different.

The practical steps to take this week

1. Schedule a visit (in-person or telehealth) with your prescribing diabetes clinician.
2. Ask for a CGM prescription specifying Dexcom G7 or FreeStyle Libre 3 Plus.
3. Choose a Medicare-approved DME supplier (ask the clinician to fax the prescription directly).
4. Keep a copy of the prescription and your most recent clinical note.
5. If the first month's supply does not arrive within 3 weeks of filing, call the supplier first, then the DME MAC (Medicare Administrative Contractor) for your state.

For private insurance coverage (non-Medicare), the rules vary by plan and state. Most commercial plans now cover CGM for insulin-treated diabetics with similar rules to Medicare. Medicaid coverage varies by state — 43 states cover CGM for type 1; the list for type 2 is still growing.

Frequently asked questions